Gilad Mai: How Much Financing Headroom Will Really Remain After Modiin
The main article identified Modiin as the 2026 bridge. This follow-up shows that the bridge is narrower than it looks: about NIS 87.8 million of expected remaining surplus from Modiin still has to stand against the remaining Series B balance, while Tzfat, Tiberias, and Nof Hagalil are already adding their own capital and financing demands.
How Much Is Really Left From Modiin
The main article argued that Modiin is the only project that can bring visible cash to the company as early as 2026. This follow-up does not revisit whether Modiin is a good project. It isolates a narrower question: how much of that bridge is actually left for the company once the debt already sitting on it and the parallel financing layers are taken into account.
That matters now for a simple reason. The board did say it does not expect a liquidity problem over the next two years, but in the same liquidity review it explicitly tested Series B and Series G debt service, project surpluses expected to be released, financing sources, and the company’s ability to complete additional fundraisings. So even on management’s own framing, the room for maneuver is not resting only on cash already sitting in the bank.
This is where Modiin becomes the key near-term source. By the report date, the company estimated that out of total expected withdrawable surplus of NIS 139.8 million from Modiin, it had already drawn NIS 52.0 million, leaving NIS 87.8 million still expected to be released, with expected timing in Q3/2026. That is a meaningful number, but it is not free corporate cushion.
The reason is that Series B sits directly on the same source. After the 2024 and 2025 repayments, the remaining Series B principal is NIS 55 million, the final repayment is due on September 30, 2026, and the coupon on the outstanding balance is 7.3% annually. More importantly, the bondholders’ collateral is the assigned right to the adjusted surplus released from Modiin. In other words, anyone reading the NIS 87.8 million as if it were unrestricted company-level cash is skipping the most important layer in the story.
That chart is intentionally conservative. It does not deduct the March and September 2026 coupons, it does not deduct holding-company overhead, and it does not assume any new equity use. Even so, what remains after the Series B principal already falls to roughly NIS 32.8 million. That means Modiin can solve the 2026 wall, but it is hard to describe it as a comfortable base for another expansion cycle.
There is one more practical yellow flag here. Modiin is a closed project-account structure, with release mechanics inside the project financing framework and with a dedicated pledge to the bondholders. So even operationally, this is not a pool that management can redeploy freely against any new need. It is first and foremost a repayment source for debt already secured on it.
There Is No Second Clean Pool After Modiin
The second easy mistake is to assume that once Modiin bridges 2026, the rest of the pipeline creates a fresh cushion. The local evidence says otherwise. Most of the next sources are either far away in timing, already encumbered, or still require capital and financing before they can produce surplus.
| Layer | What the local evidence says | Why this does not create free room |
|---|---|---|
| Series G | The series was issued in 2025 at NIS 85.4 million par, principal starts only in 2027, and its collateral is the subsidiary’s right to surplus from the Ramat Yoram Netivot project | This is not the 2026 wall, but it is not spare backup capacity either. The next surplus layer is already pledged, and the debt-to-collateral ratio stood at 70.76% at year-end |
| Tzfat | After year-end the company signed new senior financing of up to NIS 120 million at prime + 0.6%, but the mezzanine balance at the end of 2025 still stood at NIS 26.7 million at prime + 7%, and expected surplus release is only in Q4/2028 | The financing price improved, not the capital structure. Without a full Phase A permit within 12 months and real sales progress, Tzfat still consumes room before it provides it |
| Tiberias | The company signed bridge financing of up to NIS 121.5 million for 12 months or until construction lending begins, including NIS 95 million senior debt, NIS 20 million VAT financing, and NIS 6.5 million subordinated debt | This finances the path into the project. It is not a near-term liquidity source for the company. Expected surplus from Tiberias is only in Q4/2029 |
| Nof Hagalil | The tender adds 536 housing units, but it also requires about NIS 6.7 million for the land rights and about NIS 103.3 million of development payments within 90 days of the win | This is an immediate added burden before a financing provider has been selected and before the company can even estimate full project profitability or timing |
The chart makes clear why Modiin matters so much. Tzfat and Tiberias may show similar expected surplus figures on paper, but they sit two and three years further out. They do not answer the 2026 bridge question, and in the meantime they already require financing, execution milestones, and equity support.
Series G adds another constraint that is easy to miss. The company is in compliance with the series covenants, but the expansion terms require that before a full permit is received for both Netivot phases, the post-expansion debt-to-collateral ratio must not exceed 70%. At the end of 2025 the ratio already stood at 70.76%, while the company only had a permit for Phase A. So even without any covenant breach, there was not much comfortable room for more debt on that same collateral base at year-end unless the permitting status or collateral base changed meaningfully.
Tzfat tells a similar story from a different angle. The new senior pricing is clearly better, and that is real progress, but it does not erase the fact that the mezzanine layer remains in place and that the project still has to secure a full Phase A permit within 12 months while the company keeps tangible equity positive. So here too, what looks like financing relief is mostly time bought, not free flexibility created.
What This Means For Real Headroom
To understand how narrow the room is, the project picture has to be connected back to the company picture. In the consolidated statements, working capital looks positive at NIS 92.0 million, but on the 12-month adjusted view it falls to only NIS 18.5 million. That is a real gap. It means the key question is not whether the company owns project value. It does. The question is how much of that value can actually become available in time.
That leads to the practical conclusion. Modiin is a bridge, not a launch ramp. If Modiin releases the NIS 87.8 million on schedule, and if Nof Hagalil does not require unusual equity before financing closes, the company can cross the Series B wall without extreme pressure. But after that, what is left is not a wide cushion. It is a modest residual at a time when Tzfat still needs permit and sales progress, Tiberias is still on bridge funding, and Series G has already ring-fenced the Netivot collateral layer.
The most important point is not whether the company has “enough projects.” It does. The point is that after Modiin there is currently no second clean, near-term pool that can serve the company with the same ease. Tzfat and Tiberias are too far out in timing. Netivot is already tied to Series G. Nof Hagalil adds financing need before it adds certainty. That is why the real post-Modiin headroom looks much more like a buffer against delays than like fresh ammunition for another aggressive growth step.
That is the bottom line. Anyone looking at Modiin and seeing NIS 87.8 million of financing comfort is missing Series B, the 2026 coupons, the Tzfat mezzanine layer, the Tiberias bridge financing, and the Nof Hagalil burden. Modiin can still save the year. It just does not leave much room for mistakes afterward.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.